IN RE: Actos (Pioglitazone) Products Liability Litigation
United States District Court for the Western District of Louisiana
The Honorable Rebecca F. Doherty, Presiding.
Multidistrict litigation is litigation comprised of multiple civil cases involving one or more common questions of fact, but the cases are pending in different districts. Such actions may be transferred to any single district for coordinated or consolidated pretrial proceedings. These transfers are made by the United States Judicial Panel on Multidistrict Litigation authorized by 28 U.S.C. 1407. Actions will be transferred for the convenience of the parties and witnesses and to promote the just and efficient conduct of such actions. More information on multidistrict litigation can be obtained from the United States Judicial Panel on Multidistrict Litigation at http://www.jpml.uscourts.gov.
On December 29, 2011, the United States Judicial Panel on Multidistrict Litigation transferred 11 civil action(s) to the United States District Court for the Western District of Louisiana for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. 1407, assigned to the Honorable Rebecca F. Doherty.
Each of these actions alleges claims arising from the use of Actos, a prescription medication approved for use in the treatment of type 2 diabetes. Plaintiffs allege that individuals who use Actos face an increased risk of developing bladder cancer. Plaintiffs further allege that the defendants concealed their knowledge of this risk and failed to provide adequate warnings to consumers and the health care community. Defendants deny all allegations of fault.
Here, attorneys can find an introductory Welcome Letter to Counsel from the Honorable Rebecca F. Doherty, U.S. District Judge, which is intended to provide counsel entering the Actos litigation with some of the foundational information required to participate fully and effectively.